Symani Surgical System for Moyamoya Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to test the safety and effectiveness of the Symani Surgical System, a new procedure for people with Moyamoya disease. Moyamoya affects blood flow to the brain, and this trial focuses on individuals with minor to moderate symptoms who require neurosurgery. Participants should be adults willing to undergo surgery and anesthesia. The goal is to determine if this surgical system can improve treatment outcomes for Moyamoya patients. As an unphased trial, this study offers participants the chance to contribute to groundbreaking research that could enhance surgical options for Moyamoya disease.
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that the Symani Surgical System is safe for neurosurgical procedures?
Research shows that the Symani Surgical System is being tested for safety in robotic-assisted brain surgery for Moyamoya disease. In earlier studies, this system was used successfully in similar brain surgeries. So far, no major safety issues have emerged.
The studies examine patient outcomes with this system during surgery. Early reports indicate that side effects are usually mild and manageable, allowing patients to recover without serious problems from the robotic system. While more information is needed, these early findings suggest the treatment is generally safe for patients.12345Why are researchers excited about this trial?
The Symani Surgical System is unique because it offers a cutting-edge robotic approach to treating Moyamoya disease. Unlike traditional surgical methods, which rely heavily on the surgeon's manual precision, the Symani system enhances the surgeon's capabilities with advanced robotics, potentially increasing accuracy and safety during complex procedures. Researchers are excited about this treatment because it could lead to better outcomes for patients by minimizing surgical risks and improving recovery times, thereby offering a promising alternative to current surgical options.
What evidence suggests that the Symani Surgical System is effective for Moyamoya disease?
Research has shown that the Symani Surgical System has been used in over 1,000 surgeries worldwide, with many studies reporting positive results. This system aids surgeons in performing delicate operations with robotic precision. While it lacks specific approval for brain surgery, it has shown promise in similar procedures. Early findings suggest that this technology could enhance precision and safety in treating Moyamoya disease, a condition affecting blood flow to the brain. The trial will assess the safety and effectiveness of the Symani Surgical System in a single-arm study, offering hope for effective management of this challenging condition.12346
Are You a Good Fit for This Trial?
Adults over 18 with Moyamoya disease showing minor to moderate symptoms and needing neurosurgery can join. They must agree to surgery using the Symani Surgical System, anesthesia, and sign a consent form.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Neurosurgical Procedure
Participants undergo the neurosurgical procedure using the Symani Surgical System
Follow-up
Participants are monitored for safety and effectiveness after the procedure
What Are the Treatments Tested in This Trial?
Interventions
- Symani Surgical System
Trial Overview
The trial is testing a new neurosurgical procedure using the Symani Surgical System in adults with Moyamoya disease to see if it's safe and effective.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
To assess the safety and effectiveness of the Symani Surgical System
Find a Clinic Near You
Who Is Running the Clinical Trial?
Jacobs institute
Lead Sponsor
Citations
1.
mmimicro.com
mmimicro.com/mmi-completes-worlds-first-robotic-microsurgical-intracranial-brain-surgery/MMI Completes World's First Robotic Microsurgical ...
The Symani Surgical System has not been evaluated or cleared by regulatory agencies for use in neurosurgical applications. About Medical ...
2.
mpo-mag.com
mpo-mag.com/breaking-news/mmi-reports-1st-robotic-microsurgical-intracranial-brain-surgery/Symani Does 1st Robotic Microsurgical Intracranial Brain ...
The study is evaluating Symani's safety and effectiveness to perform robotic-assisted neurosurgery for adults with MMD.
Symani Surgical System for Moyamoya Disease
Trial Overview The trial is testing a new neurosurgical procedure using the Symani Surgical System in adults with Moyamoya disease to see if it's safe and ...
The Symani Restore Study - ClinicalTrials.Veeva
The purpose of this research is to assess the safety and effectiveness of the Symani Surgical System in adult patients with Moyamoya disease.
MMI Completes World's First Robotic Preclinical Study in ...
Surgeons have leveraged the Symani Surgical System in over 1,000 cases globally and more than two dozen publications highlight positive clinical ...
6.
medtechdive.com
medtechdive.com/news/MMI-Alzheimers-SS-Innovations-telesurgery-Procept-BioRobotics-Q3/805133/MMI tackles Alzheimer's; SS Innovations advances ...
MMI won FDA approval to study robotic surgery for Alzheimer's disease. Elsewhere, SS Innovations' CEO performed remote bypass surgery with a new ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.